Collplant Depreciation And Amortization from 2010 to 2024

CLGN Stock  USD 5.95  0.24  3.88%   
Collplant Biotechnologies Depreciation And Amortization yearly trend continues to be very stable with very little volatility. Depreciation And Amortization is likely to drop to about 878.7 K. Depreciation And Amortization is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. View All Fundamentals
 
Depreciation And Amortization  
First Reported
2014-06-30
Previous Quarter
272 K
Current Value
284 K
Quarterly Volatility
129.8 K
 
Yuan Drop
 
Covid
Check Collplant Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Collplant main balance sheet or income statement drivers, such as Depreciation And Amortization of 878.7 K, Interest Expense of 9.5 K or Selling General Administrative of 3.8 M, as well as many exotic indicators such as Price To Sales Ratio of 6.31, Dividend Yield of 0.0 or PTB Ratio of 2.44. Collplant financial statements analysis is a perfect complement when working with Collplant Biotechnologies Valuation or Volatility modules.
  
This module can also supplement Collplant Biotechnologies' financial leverage analysis and stock options assessment as well as various Collplant Biotechnologies Technical models . Check out the analysis of Collplant Biotechnologies Correlation against competitors.
To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.

Latest Collplant Biotechnologies' Depreciation And Amortization Growth Pattern

Below is the plot of the Depreciation And Amortization of Collplant Biotechnologies over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. Collplant Biotechnologies' Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Collplant Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Depreciation And Amortization10 Years Trend
Slightly volatile
   Depreciation And Amortization   
       Timeline  

Collplant Depreciation And Amortization Regression Statistics

Arithmetic Mean741,173
Geometric Mean492,062
Coefficient Of Variation128.87
Mean Deviation551,038
Median326,825
Standard Deviation955,133
Sample Variance912.3B
Range3.8M
R-Value0.39
Mean Square Error830.2B
R-Squared0.15
Significance0.15
Slope84,079
Total Sum of Squares12.8T

Collplant Depreciation And Amortization History

2024878.7 K
20231.1 M
20221.1 M
2021783 K
2020700 K
2019M
2018390.8 K

About Collplant Biotechnologies Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Collplant Biotechnologies income statement, its balance sheet, and the statement of cash flows. Collplant Biotechnologies investors use historical funamental indicators, such as Collplant Biotechnologies's Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although Collplant Biotechnologies investors may use each financial statement separately, they are all related. The changes in Collplant Biotechnologies's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Collplant Biotechnologies's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Collplant Biotechnologies Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Collplant Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Depreciation And Amortization1.1 M878.7 K

Pair Trading with Collplant Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collplant Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving against Collplant Stock

  0.72BMY Bristol Myers Squibb Earnings Call This WeekPairCorr
  0.59VTYX Ventyx Biosciences Financial Report 9th of May 2024 PairCorr
  0.59GOSS Gossamer Bio Earnings Call This WeekPairCorr
  0.55LYRA Lyra TherapeuticsInc Financial Report 10th of May 2024 PairCorr
  0.45GLUE Monte Rosa Therapeutics Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Collplant Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collplant Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collplant Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collplant Biotechnologies to buy it.
The correlation of Collplant Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collplant Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collplant Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Collplant Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Collplant Biotechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Collplant Biotechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Collplant Biotechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Collplant Biotechnologies Stock:
Check out the analysis of Collplant Biotechnologies Correlation against competitors.
To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.
Note that the Collplant Biotechnologies information on this page should be used as a complementary analysis to other Collplant Biotechnologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Collplant Stock analysis

When running Collplant Biotechnologies' price analysis, check to measure Collplant Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collplant Biotechnologies is operating at the current time. Most of Collplant Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Collplant Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collplant Biotechnologies' price. Additionally, you may evaluate how the addition of Collplant Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Collplant Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.962
Quarterly Revenue Growth
4.155
Return On Assets
(0.13)
Return On Equity
(0.23)
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.